ADC Therapeutics (ADCT) Change in Inventory (2023 - 2026)
ADC Therapeutics (ADCT) posted Change in Inventory of -$16000.0 for Q1 2026, down 101.88% sequentially from $853000.0 in Q4 2025, and down 105.23% YoY from $306000.0 in Q1 2025.
ADC Therapeutics (ADCT) Change in Inventory (2023 - 2026) Analysis & Trends
ADC Therapeutics has reported Change in Inventory for 4 years, with the latest figure at -$16000.0 in Q1 2026.
- Quarterly Change in Inventory fell 105.23% year-over-year to -$16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 40.59% YoY) and the FY2025 annual result came in at $2.4 million, down 36.13% from the prior year.
- Change in Inventory retreated to -$16000.0 in Q1 2026 per ADCT's latest filing, from $853000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $3.5 million in Q3 2023 and troughed at -$518000.0 in Q2 2024.
- A 4-year average of $908076.9 and a median of $568000.0 in 2024 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 1775.45% in 2024, down 125.24% in 2024.
- Over 4 years, Change in Inventory stood at -$167000.0 in 2023, then soared by 1775.45% to $2.8 million in 2024, then sank by 69.51% to $853000.0 in 2025, then slumped by 101.88% to -$16000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$16000.0, $853000.0, and $516000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Mn |
| Jun 30, 2026 | 3.29 Mn |
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | 853,000.00 |
| Dec 31, 2025 | 853,000.00 |
| Sep 30, 2025 | 516,000.00 |
| Sep 30, 2025 | 516,000.00 |
| Jun 30, 2025 | 706,000.00 |
| Jun 30, 2025 | 706,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 880,000.00 |
| Sep 30, 2024 | 880,000.00 |
| Jun 30, 2024 | -518,000.00 |
| Jun 30, 2024 | -518,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Mar 31, 2024 | 568,000.00 |